ETEA inhibitors belong to a distinctive chemical class renowned for their capacity to modulate cellular processes through the selective inhibition of ETEA, a pivotal enzyme. ETEA, standing for Enzyme Targeting Eukaryotic Aminoacylation, plays a crucial role in cellular metabolism by catalyzing the aminoacylation of transfer RNA (tRNA). This enzymatic process is fundamental for protein synthesis, as it ensures the accurate pairing of amino acids with their corresponding tRNAs during translation. ETEA inhibitors are characterized by their ability to interact specifically with the active site of the ETEA enzyme, disrupting its catalytic function and impeding the aminoacylation process. This intricate interference with protein synthesis makes ETEA inhibitors a subject of intense research and exploration in the realm of molecular biology and biochemistry.
ETEA inhibitors exhibit a diverse array of chemical compositions, often characterized by a core scaffold that facilitates binding to the active site of the ETEA enzyme. The design and optimization of these inhibitors involve a meticulous understanding of the enzyme's structure-activity relationship, allowing for the development of compounds with enhanced potency and selectivity. Researchers focus on unraveling the intricacies of ETEA inhibition, not only to expand the repertoire of chemical tools available for dissecting cellular processes but also to deepen our understanding of the molecular mechanisms governing protein synthesis. The study of ETEA inhibitors thus stands at the forefront of molecular research, contributing valuable insights into the regulation of cellular functions at the molecular level.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that can inhibit a wide range of protein kinases by mimicking ATP binding. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
An inhibitor that targets the ATP-binding site of tyrosine kinases and can inhibit receptor tyrosine kinases. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
A multi-kinase inhibitor that blocks the activity of several protein kinases. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A chemical that inhibits PI3K, a kinase involved in many signaling pathways, thus altering downstream effects. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A selective inhibitor of MEK, which may impact kinases downstream of MEK in the signaling cascade. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which can modulate kinase activity in stress response pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A specific inhibitor of p38 MAP kinase, involved in inflammatory responses and stress signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor that can affect various kinases implicated in growth and survival signaling. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
An Src family kinase inhibitor, which can alter signaling pathways involving these kinases. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
A broad-spectrum tyrosine kinase inhibitor that can inhibit a wide range of tyrosine kinases within signaling pathways. | ||||||